Selection of the optimal dose for an ultra-short course subcutaneous immunotherapy (SCIT) for Rhinoconjunctivitis for Birch Allergic patients

A SCIT that is both efficacious and ultra-short course in its administration is an ideal therapy for allergic rhinoconjunctivitis. This combination facilitates adherence, but must not compromise safety.